CLINICAL RESEARCH OF A SIDDHA MEDICINE VEERIYA VIRUTHI CHOORANAM IN THE TREATMENT OF AAN MALADU(MALE INFERTILITY)

CLINICAL STUDY ON AAN MALADU(MALE INFERTILITY)AND DRUG OF CHOICE IS VEERIYA VIRUTHI CHOORANAM.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/01/004278

Enrollment

Registered

2014-01-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- AAN MALADU (MALE INFERTILITY)

Interventions

Intervention1: VEERIYA VIRUTHI CHOORANAM: 8 gm of Veeriya viruthu chooranam will be administerd orally twice a day along with milk after food for a period of 90 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male infertile 2. Age 21- 45 year 3. Maritial status - more than 1 year 4. Sperm count 5. Motility less than 6. Patient is willing to sign the informed consent stating that he will continuously stick to the treatment during 48days but can opt out of the trial of his own conscious discretion. 7. Patients who are willing to give specimen of blood , urine and semen before and after treatment.

Exclusion criteria

Exclusion criteria: 1. Azoospermia 2. Hydrocele 3. Diabetes mellitus 4. Hypertension 5. Endocrine disorders 6. Caridiac diseases 7. VDRL & STD 8. Inguinal Hernia 9. Renal diseases 10. Varicose veins

Design outcomes

Primary

Measure	Time frame
Outcome is mainly assessed by increase in the sperm count and motility %Timepoint: PRE STUDY SCREENING AND AFTER TREATMENT	—

Secondary

Measure	Time frame
CLINICAL ASSESSMENTTimepoint: PRE STUDY SCREENING AND AFTER TREATMENT	—

Countries

India

Contacts

Public ContactDR H VETHA MERLIN KUMARI

NATIONAL INSTITUTE OF SIDDHA

drmohan139@gmail.com044-22411611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026